<DOC>
	<DOCNO>NCT00476606</DOCNO>
	<brief_summary>To evaluate clinical immunological outcome child treat HAART .</brief_summary>
	<brief_title>A Prospective Cohort Children With HIV Infection</brief_title>
	<detailed_description>This long term cohort study start 2002 . Currently , 120 child enrol study receive HIV care accord standard practice set Thai Ministry Public Health . HIV-infected parent also receive care clinic .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<mesh_term>Indinavir</mesh_term>
	<mesh_term>Saquinavir</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<criteria>Children part ATC program Chulalongkorn hospital HIVNAT , The Thai Red Cross AIDS research center Children fulfil criterion start HAART accord ATC program Children switch second regimen salvage therapy Children antiretroviral regimen , include post trial child HIVNAT study ( HIVNAT Khon Kaen University sit ) Children HIV infection antiretroviral therapy Caretakers understand purpose data plasma sample collection , sign consent form Patients caretaker may choose stop HAART anytime study . If agree , would continue follow study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HIV child</keyword>
	<keyword>HAART</keyword>
	<keyword>ARV</keyword>
	<keyword>Second line HAART</keyword>
	<keyword>Viral Load</keyword>
	<keyword>Combination drug</keyword>
	<keyword>Treatment Experienced</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>